Irie, Toshiaki

Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography

Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 300

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease

Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Suzuki, K., & Irie, T. (1997) · The Lancet

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 259

In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: A PET and MRI study

Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 75

Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study

Shimada, H., Hirano, S., Sinotoh, H., Ota, T., Tanaka, N., Sato, K., Yamada, M., Fukushi, K., Irie, T., Zhang, M. R., et al. (2015) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 40

A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain as a reference

Namba, H., Nakagawa, K., Iyo, M., Fukushi, K., & Irie, T. (1994) · European Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 13